| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Chief Executive Officer | Common Stock | 646K | $10.4M | $16.05 | Aug 15, 2024 | Direct |
| NEOGENOMICS INC | Chief Executive Officer | Performance Stock Unit | 172K | $2.77M | $16.05 | Aug 15, 2024 | Direct |
| NEOGENOMICS INC | Chief Executive Officer | Restricted Stock Unit | 172K | $2.77M | $16.05 | Aug 15, 2024 | Direct |
| QuidelOrtho Corp | Director | Common Stock | 33.3K | $2.31M | $69.22 | Jun 6, 2023 | By Trust |
| NEOGENOMICS INC | Chief Executive Officer | Restricted Stock Unit | 96.1K | $1.43M | $14.86 | May 11, 2024 | Direct |
| QuidelOrtho Corp | Director | Common Stock | 2.25K | $156K | $69.22 | Jun 6, 2023 | Direct |
| NEOGENOMICS INC | Chief Executive Officer | Stock Option (Right to Buy) | 288K | Aug 15, 2024 | Direct | ||
| Akouos, Inc. | Director | Stock Option (right to buy) | 16K | Jun 23, 2022 | Direct | ||
| Ortho Clinical Diagnostics Holdings plc | Chairman and CEO, Director | Ordinary Shares, $0.00001 par value | 0 | $18.77 | May 27, 2022 | Direct | |
| Ortho Clinical Diagnostics Holdings plc | Chairman and CEO, Director | Stock Option | 0 | May 27, 2022 | Direct | ||
| QuidelOrtho Corp | Director | Restricted Stock Units (Equity Grant) | 0 | Jun 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | Aug 15, 2024 | 1 | $0 | 4 | Aug 19, 2024 | Chief Executive Officer |
| NEO | NEOGENOMICS INC | May 11, 2024 | 3 | -$281K | 4/A | Dec 4, 2024 | Chief Executive Officer |
| NEO | NEOGENOMICS INC | Feb 23, 2024 | 3 | $0 | 4 | Feb 27, 2024 | Chief Executive Officer |
| QDEL | QuidelOrtho Corp | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
| QDEL | QuidelOrtho Corp | May 27, 2023 | 1 | -$105K | 4 | May 31, 2023 | Director |
| QDEL | QuidelOrtho Corp | May 24, 2023 | 3 | $0 | 4 | May 25, 2023 | Director |
| NEO | NEOGENOMICS INC | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | Chief Executive Officer |
| NEO | NEOGENOMICS INC | Aug 15, 2022 | 3 | $0 | 4 | Aug 17, 2022 | Chief Executive Officer |
| NEO | NEOGENOMICS INC | Aug 15, 2022 | 0 | $0 | 3 | Aug 17, 2022 | Chief Executive Officer |
| AKUS | Akouos, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| QDEL | QuidelOrtho Corp | Jun 6, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| QDEL | QuidelOrtho Corp | May 27, 2022 | 1 | $0 | 4/A | Aug 1, 2022 | Director |
| QDEL | QuidelOrtho Corp | May 27, 2022 | 0 | $0 | 3 | Jun 1, 2022 | Director |
| OCDX | Ortho Clinical Diagnostics Holdings plc | May 27, 2022 | 2 | $0 | 4 | Jun 1, 2022 | Chairman and CEO, Director |
| OCDX | Ortho Clinical Diagnostics Holdings plc | Jan 3, 2022 | 3 | -$854K | 4 | Jan 5, 2022 | Chairman and CEO, Director |
| OCDX | Ortho Clinical Diagnostics Holdings plc | Aug 2, 2021 | 3 | -$5.89M | 4 | Aug 4, 2021 | Chairman and CEO, Director |
| AKUS | Akouos, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |